((This Jan. 13 story has been corrected to say 'drugmakers will ask,' not 'Eli Lilly has asked' to pause negotiations, after ...

Eli Lilly has asked the U.S. government to pause price negotiations for prescription drugs, Bloomberg News reported on Monday ...

Millions of Medicare enrollees are likely to see relief in 2025 when a $2,000 cap on out-of-pocket prescription drug-spending ...

Noom releases a significant update of its innovative GLP-1 companion to improve medication persistence and adherence while ...

A case involving counterfeit and prescription drugs sold by mail resulted in a Michigan man getting prison time.

After failing to gain traction in previous years, legislation to establish a Prescription Drug Affordability Board (PDAB) is ...

Medicare’s drug pricing negotiations — the first of their kind in the United States, passed under President Joe Biden — face ...

Drug pricing is influenced by numerous factors, but technology has the potential to strike the critical balance between ...

After striking out last session, a plan for Illinois to import less-expensive prescription drugs from Canada for health plans ...

Zepbound is a dual-activating medication that combines glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like ...

Medicare recipients who take expensive prescriptions will get a break this year with a $2,000 cap on drug costs.